2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC
Announces Pricing of Public Offering of Common Stock
Investor Presentation
Humacyte, Inc. Increases Authorized Shares to 550 Million
Other Events
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Expands Commercial and Business Development Opportunities Through Realignment of Ex-U.S. Rights to Symvess®
Announces Pricing of $20 Million Registered Direct Offering of Common Stock
Q1
FY 2025
Q3
Q2
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload